Patient
P2B-044
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · M.S. Ramaiah Medical College and Hospitals (Bangalore, India) (Dr. Reyes)
consented 2012-10-24
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
Grade 3 neutropenia with onset in cycle 4 (2013-01-17); assessed as related to study drug (probable); resolved 2013-01-26; action: drug interrupted.
Grade 2 alopecia with onset in cycle 1 (2012-11-25); assessed as related to study drug (probable); not resolved at last follow-up.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.